[In vitro antifungal activity of rilopirox, a new hydroxypyridone antimycotic agent].
In vitro antifungal activities of rilopirox (RIL), a new topical hydroxypyridone antifungal agent, were studied against 7 species (31 strains) of yeast-like fungi and 15 species (17 strains) of mycerial fungi from stock cultures of a wide range of medically important fungi. Tests were carried out by the liquid dilution method using Neopeptone dextrose broth with ciclopirox olamine (CPO) and oxiconazole nitrate (OCZ) as reference drugs. RIL exhibited a broad spectrum of antifungal activities; the MIC of RIL against yeasts were about 1 microgram/ml, those against other fungi were 0.5-4 micrograms/ml. Antifungal activities were similar to CPO, and compare to OCZ, RIL showed characteristically little differences in its activities against different species or strains of target organisms.
Harada
I
I
Teikyo University Institute of Medical Mycology.
Mitsui
K
K
Uchida
K
K
Yamaguchi
H
H
D000935:Antifungal Agents / Q000494:pharmacology*; D003883:Arthrodermataceae / Q000187:drug effects; D002176:Candida albicans / Q000187:drug effects; D003904:Mitosporic Fungi / Q000187:drug effects; D011728:Pyridones / Q000494:pharmacology*; D012441:Saccharomyces cerevisiae / Q000187:drug effects
D000935:Antifungal Agents; D011728:Pyridones; C066307:rilopirox